Monopar Therapeutics Inc. Increase (Decrease) in Other Operating Liabilities
Monopar Therapeutics Inc. (MNPR) reported Increase (Decrease) in Other Operating Liabilities of $0 for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2023-05-11
- Monopar Therapeutics Inc. increase (decrease) in other operating liabilities for the quarter ending 2023-03-31 was $0.00.
- Monopar Therapeutics Inc. increase (decrease) in other operating liabilities for the quarter ending 2022-09-30 was $4.49K.
- Monopar Therapeutics Inc. increase (decrease) in other operating liabilities for the quarter ending 2022-06-30 was -$1.86K.
- Monopar Therapeutics Inc. increase (decrease) in other operating liabilities for the quarter ending 2022-03-31 was -$2.38K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month |
|---|---|---|---|
| 2023-03-31 | $0.00 10-Q · filed 2023-05-11 | ||
| 2022-09-30 | $4.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $2.63K derived: sum of 2 quarters · filed 2022-11-10 | $249.00 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$1.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$4.24K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | -$2.38K 10-Q · filed 2023-05-11 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $0.00 10-Q · filed 2022-08-11 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |